User:ParentCatPansy
Editor·9,366 edits·since 2024/10
ParentCatPansy is an editor on PeptidePedia Wiki, editing since 2024 / 10.
This editor works mainly on categorisation and navigation. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
9,366Total edits
21Logged here
17Articles touched
2024/10Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is categorisation and navigation.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| Syringe dead space | 1 | 31 | 3% |
| Lixisenatide | 1 | 26 | 4% |
| Peptide | 1 | 41 | 2% |
| Global access disparity | 1 | 31 | 3% |
| Adverse effects of GLP-1 receptor agonists | 1 | 44 | 2% |
| Peptide supply chain | 1 | 39 | 3% |
| SURPASS trial programme | 1 | 35 | 3% |
| Placebo-adjusted effect | 1 | 28 | 4% |
| Peptide harm reduction | 1 | 39 | 3% |
| Intention-to-treat analysis | 1 | 26 | 4% |
| GLP-1 receptor agonist | 1 | 43 | 2% |
| Shanghai Sigma-Audley New Material Technology | 1 | 37 | 3% |
| International nonproprietary name | 1 | 31 | 3% |
| Dulaglutide | 1 | 26 | 4% |
Awards
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.